Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Spinal Cord Neoplasms × Esketamine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pain, Postoperative 2 Spinal Cord Neoplasms 1

Interventions

Vorinostat 1 Temozolomide 1 Saline Solution 1 Pregabalin 1 Minocycline 1 Immunoglobulin G 1 Esketamine 1 Disulfides 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05096468 2023-07-06

Esketamine Combined With Pregabalin on Acute Postoperative Pain in Patients Undergoing Resection of Spinal Neoplasms.

Beijing Tiantan Hospital

Phase 2/3 Completed

Pain, Postoperative, Spinal Cord Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡